Last Tuesday (November 18th), we had the privilege of participating in person in the CADIFA 2025 Seminar at Anvisa headquarters.
The event aimed to present updates related to CADIFA, including the main items requested in deficiency letters, reasons for rejections, management of changes in approved CADIFAs, as well as highlighting key points of attention for the sector and the agency’s future challenges involving the CADIFA topic.
Furthermore, data related to CBPF requests and the agency’s efforts in utilizing approaches aimed at accelerating process analysis were presented.
For both topics, CADIFA and CBPF, relevant points were raised regarding optimized analysis procedures and the requirements for adherence and correct use of this regulatory approach, which speeds up the approval of processes submitted to ANVISA, generating impact where it really matters: the health of the population through access to quality medicines.
It was an excellent event that brought us transparency regarding the activities conducted by the agency and reinforced our certainty that TM Consultancy’s mission as a facilitator of regulatory processes and promoter of health in Brazil is completely aligned with ANVISA’s strategies and objectives.
Thank you to Anvisa for the presentations and everyone involved in making this event happen!
